mk 912 has been researched along with l 659066 in 2 studies
| Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) | Studies (l 659066) | Trials (l 659066) | Recent Studies (post-2010) (l 659066) |
|---|---|---|---|---|---|
| 60 | 3 | 2 | 79 | 40 | 57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clineschmidt, BV; Hucker, HB; Huff, JR; Lis, EV; Lotti, VJ; Pettibone, DJ; Reiss, DR; Sweeney, BM; Vacca, J | 1 |
| Campbell, WR; Potter, DE | 1 |
2 other study(ies) available for mk 912 and l 659066
| Article | Year |
|---|---|
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.
Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood-Brain Barrier; Callitrichinae; Clonidine; Decerebrate State; Dihydroxyphenylalanine; Gastrointestinal Motility; Male; Muscle Contraction; Quinolizines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vas Deferens; Yohimbine | 1988 |
The central effects of moxonidine on intraocular pressure and its antagonism by L-659, 066 and L-657, 743 in the rabbit.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Intraocular Pressure; Male; Pupil; Quinolizines; Rabbits | 1994 |